Skip to content
AnzuPartners
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent

BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities

Bioflyte

Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents

InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO

Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts

6K Additive Awarded Five-Year Blanket Purchase Agreement With the US Army Development Command

New BPA helps the US Army ensure national security while allowing weapons development from domestic feedstock of critical materials from 6K Additive’s UniMelt® production process

NUBURU Strengthens Executive Management Team

Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.

Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies

Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.

Aspinity Raises $5 Million Series B Funding to Bring Breakthrough AI/ML Technology to a Global Market

Strategic partnership with Unitrontech accelerates time to market for AI-based automotive impact and other AIoT solutions

Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development

Dr. Vander Horn’s expertise will further advance NanoCellect’s ability to deliver innovative solutions to the cellular research markets

Anzu Partners Elects Cathryn Paine to Partner

Anzu Partners Elects Cathryn Paine to Partner

BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization

As a part of the NIST Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products.

Niron Magnetics Expands its Focus on Government Relations with New Vice President of Government Affairs and New Board Member

Mark Schramek and Don Rosenberg bring extensive experience in government affairs and global policy to support Niron Magnetics’ corporate outreach and commercialization

← Previous
Next →

QUICK LINKS

About

Portfolio

Team

RESOURCES

Press Releases

Newsroom

Newsletter

GET IN TOUCH

Company Questionnaire

Talent

Contact Us

Investor Portal

CONNECT WITH US

Twitter Linkedin

© 2025 Anzu Partners

Privacy Policy

Supplier Code of Business Conduct

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT